G
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is CCOPC22-007395 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2022-06, May 26, 2022.
The North American Industry Classification System (NAICS) code for this procurement is 334516, Analytical Laboratory Instrument Manufacturing, with a size standard of 1000 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.
The Labatory of Diganostic Radiology and Research (LDRR) and Hammoud Lab within the NIH Clinical center intends to procure bioanalyzer instrument. This is a necessary instrument for the LDRR lab to evaluate the quality of DNA/RNA and protein samples for downstream use of next-gen sequencing (NGS) genomic and proteomic techniques. LDRR lab and Hammoud lab routinely perform NGS techniques on materials isolated cell and tissue samples. NGS applications require samples to be of a known purity which will be determined by the Bioanalyzer. The Bioanalyzer uses proprietary algorithms to calculate such purity values (e.g. RNA integrity number or RIN) that are standard for almost all downstream NGS analyses.
2100 Bioanalyzer Instrument Catalog #:G2939BA
Specifications
The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. By submitting an offer in response to this RFQ, confirms acceptance that the government terms and conditions will prevail over the award. The award will be based on the following: the capability to meet the brand name requirement and price.
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (NOV 2021)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2022)
FAR 52.204-7 System for Award Management (OCT 2018)
(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)
The following FAR contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2021)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (MAY 2022)
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (NOV 2021)
FAR 52.204-13 System for Award Management Maintenance (Oct 2018)
52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.
Submission shall be received not later than August 4, 2022 @ 4:00 pm EST
Offers may be e-mailed to Gail Akinbinu ([email protected]). Offers shall include RFQ number in the subject line (CCOPC22-007395). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)
All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Gail Akinbinu([email protected])
Attachments/Links
Request AccessDownload All Attachments/Links
Attachments